Projects per year
Personal profile
Campus career
附属病院 講師 2017/07/01-2019/05/31
医学科 准教授 2019/06/01-2019/09/30
分子病態医学系 准教授 2019/06/01-2019/09/30
医学科 准教授 2019/10/01-
医学系 准教授 2019/10/01-
医学部医学科 基幹教員
学部運営への参画状況・・・有-教務委員会他
担当授業科目に係る状況・・・主要授業科目担当
Research interests
肝細胞癌の治療法の開発
肝疾患の病態の免疫学的解析
Research Fields, Keywords
- Hepatology
- Immunology
Field of expertise (Grants-in-aid for Scientific Research classification)
- Gastroenterology
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 2 Finished
-
Tm mapping法による肝硬変腹水中の細菌の同定・定量と自然免疫応答の解析
Tajiri, K. (PI) & Niimi, H. (CoI)
2020/04/01 → 2023/03/31
Project: Research
-
Analysis of HBsAg and its immune response with novel high sensitivity method
Tajiri, K. (PI)
2017/04/01 → 2021/03/31
Project: Research
-
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection
Tajiri, K., Hayashi, Y., Murayama, A., Muraishi, N., Minemura, M. & Yasuda, I., 2025/01, In: Viruses. 17, 1, 44.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice
RELPEC Group and HCC 48 Group, 2025/03, In: Hepatology Research. 55, 3, p. 444-453 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
Naganuma, A., Kakizaki, S., Hiraoka, A., Tada, T., Hatanaka, T., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Tsuji, K., Ishikawa, T., Tajiri, K., Toyoda, H., Ogawa, C., Nishikawa, H., Nishimura, T., Kawata, K. & Kosaka, H. & 23 others, , 2025/01, In: Cancer Medicine. 14, 2, e70618.Research output: Contribution to journal › Article › peer-review
Open Access -
Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib
Ohama, H., Hiraoka, A., Tada, T., Hirooka, M., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Tsuji, K., Ishikawa, T., Tajiri, K., Ochi, H., Yasuda, S., Toyoda, H., Ogawa, C., Nishimura, T., Hatanaka, T. & Kakizaki, S. & 25 others, , 2025/12, In: Scientific Reports. 15, 1, 72.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Impact of time-of-day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study
the Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan), 2025/05, In: Hepatology Research. 55, 5, p. 741-751 11 p.Research output: Contribution to journal › Article › peer-review
Datasets
-
Supplementary Material for: Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma
Hiraoka, A. (Creator), Kumada, T. (Creator), Tada, T. (Creator), Fukunishi, S. (Creator), Atsukawa, M. (Creator), Hirooka, M. (Creator), Tsuji, K. (Creator), Ishikawa, T. (Creator), Takaguchi, K. (Creator), Kariyama, K. (Creator), Itobayashi, E. (Creator), Tajiri, K. (Creator), Shimada, N. (Creator), Shibata, H. (Creator), Ochi, H. (Creator), Kawata, K. (Creator), Toyoda, H. (Creator), Ohama, H. (Creator), Tsutsui, A. (Creator), Itokawa, N. (Creator), Hayama, K. (Creator), Arai, T. (Creator), Imai, M. (Creator), Nakamura, S. (Creator), Michitaka, K. (Creator), Hiasa, Y. (Creator) & Kudo, M. (Creator), Karger Publishers, 2020
DOI: 10.6084/m9.figshare.11898228, https://karger.figshare.com/articles/Supplementary_Material_for_Nutritional_Index_as_Prognostic_Indicator_in_Patients_Receiving_Lenvatinib_Treatment_for_Unresectable_Hepatocellular_Carcinoma/11898228
Dataset
-
Supplementary Material for: Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
Hiraoka, A. (Creator), Kumada, T. (Creator), Atsukawa, M. (Creator), Hirooka, M. (Creator), Tsuji, K. (Creator), Ishikawa, T. (Creator), Takaguchi, K. (Creator), Kariyama, K. (Creator), Itobayashi, E. (Creator), Tajiri, K. (Creator), Shimada, N. (Creator), Shibata, H. (Creator), Ochi, H. (Creator), Tada, T. (Creator), Toyoda, H. (Creator), Nouso, K. (Creator), Tsutsui, A. (Creator), Nagano, T. (Creator), Itokawa, N. (Creator), Hayama, K. (Creator), Imai, M. (Creator), Joko, K. (Creator), Tanaka, H. (Creator), Tamai, T. (Creator), Koizumi, Y. (Creator), Hiasa, Y. (Creator), Michitaka, K. (Creator) & Kudo, M. (Creator), Karger Publishers, 2019
DOI: 10.6084/m9.figshare.8869625, https://karger.figshare.com/articles/Supplementary_Material_for_Important_Clinical_Factors_in_Sequential_Therapy_Including_Lenvatinib_against_Unresectable_Hepatocellular_Carcinoma/8869625
Dataset
-
Supplementary Material for: Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study
Rossari, F. (Contributor), Tada, T. (Contributor), Suda, G. (Contributor), Shimose, S. (Contributor), Kudo, M. (Contributor), Yoo, C. (Contributor), Cheon, J. (Contributor), Finkelmeier, F. (Contributor), Lim, H. Y. (Contributor), Masi, G. (Contributor), Bergamo, F. (Contributor), Amadeo, E. (Contributor), Vitiello, F. (Contributor), Kumada, T. (Contributor), Iwamoto, H. (Contributor), Aoki, T. (Contributor), Chon, H. J. (Contributor), Himmelsbach, V. (Contributor), Iavarone, M. (Contributor), Cabibbo, G. (Contributor), Montes, M. (Contributor), Foschi, F. G. (Contributor), Vivaldi, C. (Contributor), Soldà, C. (Contributor), Sho, T. (Contributor), Niizeki, T. (Contributor), Nishida, N. (Contributor), Steup, C. (Contributor), Hirooka, M. (Contributor), Kariyama, K. (Contributor), Tani, J. (Contributor), Atsukawa, M. (Contributor), Takaguchi, K. (Contributor), Itobayashi, E. (Contributor), Fukunishi, S. (Contributor), Tsuji, K. (Contributor), Ishikawa, T. (Contributor), Tajiri, K. (Contributor), Ochi, H. (Contributor), Yasuda, S. (Contributor), Toyoda, H. (Contributor), Ogawa, C. (Contributor), Nishimura, T. (Contributor), Hatanaka, T. (Contributor), Kakizaki, S. (Contributor), Shimada, N. (Contributor), Kawata, K. (Contributor), Hiraoka, A. (Contributor), Tada, F. (Contributor), Ohama, H. (Contributor), Nouso, K. (Contributor), Morishita, A. (Contributor), Tsutsui, A. (Contributor), Nagano, T. (Contributor), Itokawa, N. (Contributor), Okubo, T. (Contributor), Imai, M. (Contributor), Kosaka, H. (Contributor), Naganuma, A. (Contributor), Koizumi, Y. (Contributor), Nakamura, S. (Contributor), Kaibori, M. (Contributor), Iijima, H. (Contributor), Hiasa, Y. (Contributor), Persano, M. (Contributor), Foti, S. (Contributor), Camera, S. (Contributor), Stefanini, B. (Contributor), Scartozzi, M. (Contributor), Cascinu, S. (Contributor), Casadei-Gardini, A. (Contributor) & Rimini, M. (Contributor), Karger Publishers, 2024
DOI: 10.6084/m9.figshare.25573983.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Disease_etiology_impact_on_outcomes_of_hepatocellular_carcinoma_patients_treated_with_atezolizumab_plus_bevacizumab_a_real-world_multicenter_study/25573983/1
Dataset
-
Supplementary Material for: Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma
Hiraoka, A. (Creator), Kumada, T. (Creator), Tada, T. (Creator), Fukunishi, S. (Creator), Atsukawa, M. (Creator), Hirooka, M. (Creator), Tsuji, K. (Creator), Ishikawa, T. (Creator), Takaguchi, K. (Creator), Kariyama, K. (Creator), Itobayashi, E. (Creator), Tajiri, K. (Creator), Shimada, N. (Creator), Shibata, H. (Creator), Ochi, H. (Creator), Kawata, K. (Creator), Toyoda, H. (Creator), Ohama, H. (Creator), Tsutsui, A. (Creator), Itokawa, N. (Creator), Hayama, K. (Creator), Arai, T. (Creator), Imai, M. (Creator), Nakamura, S. (Creator), Michitaka, K. (Creator), Hiasa, Y. (Creator) & Kudo, M. (Creator), Karger Publishers, 2020
DOI: 10.6084/m9.figshare.11898228.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Nutritional_Index_as_Prognostic_Indicator_in_Patients_Receiving_Lenvatinib_Treatment_for_Unresectable_Hepatocellular_Carcinoma/11898228/1
Dataset
-
Supplementary Material for: Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study
Rossari, F. (Contributor), Tada, T. (Contributor), Suda, G. (Contributor), Shimose, S. (Contributor), Kudo, M. (Contributor), Yoo, C. (Contributor), Cheon, J. (Contributor), Finkelmeier, F. (Contributor), Lim, H. Y. (Contributor), Masi, G. (Contributor), Bergamo, F. (Contributor), Amadeo, E. (Contributor), Vitiello, F. (Contributor), Kumada, T. (Contributor), Iwamoto, H. (Contributor), Aoki, T. (Contributor), Chon, H. J. (Contributor), Himmelsbach, V. (Contributor), Iavarone, M. (Contributor), Cabibbo, G. (Contributor), Montes, M. (Contributor), Foschi, F. G. (Contributor), Vivaldi, C. (Contributor), Soldà, C. (Contributor), Sho, T. (Contributor), Niizeki, T. (Contributor), Nishida, N. (Contributor), Steup, C. (Contributor), Hirooka, M. (Contributor), Kariyama, K. (Contributor), Tani, J. (Contributor), Atsukawa, M. (Contributor), Takaguchi, K. (Contributor), Itobayashi, E. (Contributor), Fukunishi, S. (Contributor), Tsuji, K. (Contributor), Ishikawa, T. (Contributor), Tajiri, K. (Contributor), Ochi, H. (Contributor), Yasuda, S. (Contributor), Toyoda, H. (Contributor), Ogawa, C. (Contributor), Nishimura, T. (Contributor), Hatanaka, T. (Contributor), Kakizaki, S. (Contributor), Shimada, N. (Contributor), Kawata, K. (Contributor), Hiraoka, A. (Contributor), Tada, F. (Contributor), Ohama, H. (Contributor), Nouso, K. (Contributor), Morishita, A. (Contributor), Tsutsui, A. (Contributor), Nagano, T. (Contributor), Itokawa, N. (Contributor), Okubo, T. (Contributor), Imai, M. (Contributor), Kosaka, H. (Contributor), Naganuma, A. (Contributor), Koizumi, Y. (Contributor), Nakamura, S. (Contributor), Kaibori, M. (Contributor), Iijima, H. (Contributor), Hiasa, Y. (Contributor), Persano, M. (Contributor), Foti, S. (Contributor), Camera, S. (Contributor), Stefanini, B. (Contributor), Scartozzi, M. (Contributor), Cascinu, S. (Contributor), Casadei-Gardini, A. (Contributor) & Rimini, M. (Contributor), Karger Publishers, 2024
DOI: 10.6084/m9.figshare.25573983, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Disease_etiology_impact_on_outcomes_of_hepatocellular_carcinoma_patients_treated_with_atezolizumab_plus_bevacizumab_a_real-world_multicenter_study/25573983
Dataset
Courses
-
消化器疾患
Takahara, T., Kajiura, S., Minemura, M., Fujinami, H., Yoshioka, I., Shibuya, K., Hirano, K., Tajiri, K., Fujii, T., Yasuda, I., Okabe, M., Ando, T., Naruto, N., Miwa, T., Watanabe, T. & Shimada, S. 2024/10/01 → 2025/03/31
Course
-
消化器疾患
Minemura, M., Fujinami, H., Yoshioka, I., Shibuya, K., Hirano, K., Motoo, I., Tajiri, K., Fujii, T., Yasuda, I., Okabe, M., Ando, T., Naruto, N., Miwa, T., Watanabe, T., Hirabayashi, K., Hashimoto, I. & Watanabe, K. 2023/10/01 → 2024/03/31
Course
-
基礎臨床医科学概論
Mori, H., Inadera, H., Hirota, K., Fukahara, K., Okumura, T., Nishiyama, N., Kuroda, S., Nagashima, H., Tajiri, K., Sato, T., Satake, T., Ozawa, T., Akai, T. & Takao, K. 2023/04/13 → 2023/06/13
Course
-
基礎臨床医科学概論
Mori, H., Inadera, H., Hirota, K., Fukahara, K., Okumura, T., Nishiyama, N., Kuroda, S., Nagashima, H., Tajiri, K., Sato, T., Satake, T., Ozawa, T., Akai, T. & Takao, K. 2023/04/13 → 2023/06/13
Course
-
基礎臨床医科学概論
Mori, H., Inadera, H., Hirota, K., Fukahara, K., Okumura, T., Nishiyama, N., Kuroda, S., Nagashima, H., Tajiri, K., Sato, T., Satake, T., Ozawa, T., Akai, T. & Takao, K. 2023/04/13 → 2023/06/13
Course